FDA Issues Warning on Regadenoson, AdenosineFDA Issues Warning on Regadenoson, Adenosine

Clinicians should avoid using these imaging agents for cardiac nuclear stress tests of patients with unstable angina or cardiovascular instability lest their odds of a fatal heart attack increase. News Alerts
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news